Company news

Sensorion SAS news in 2025

Sensorion SAS's news releases, calls and decks from 2025, newest first.

View company

Sensorion to Present at the 44th Annual J.P. Morgan Healthcare Conference

December 19, 2025

Sensorion Reports Independent Data Monitoring Committee Raises No Safety Concerns and Agrees to Continue SENS-501’s Audiogene Phase 1/2 Trial

December 8, 2025

Sensorion Reports 2025 Half-Year Results, Provides Corporate Update and Announces Availability of Half-Year Report

September 17, 2025

Sensorion Announces its Participation in the 60th Annual Inner Ear Biology Workshop

September 4, 2025

Sensorion Announces an Increase in Resources Allocated to the Liquidity Contract with Kepler Cheuvreux

August 15, 2025

Sensorion Announces Its Participation In Upcoming Investor Conferences

July 31, 2025

Sensorion Completes Patient Enrollment of the Second Cohort in Audiogene Phase 1/2 Gene Therapy Clinical Trial

July 29, 2025

Sensorion Announces Preliminary Positive Data from the First Cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial

July 1, 2025

Sensorion Publishes Results of Combined Shareholders’ General Meeting Resolutions

May 13, 2025

Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting

May 6, 2025

Sensorion Announces Presentation by Pr. Natalie Loundon at the 2025 American Society of Pediatric Otolaryngology Annual Meeting

April 25, 2025

Decks in 2025